These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 38218752)
41. Whole-body magnetic resonance imaging evaluation of facioscapulohumeral muscular dystrophy. Leung DG; Carrino JA; Wagner KR; Jacobs MA Muscle Nerve; 2015 Oct; 52(4):512-20. PubMed ID: 25641525 [TBL] [Abstract][Full Text] [Related]
42. Atypical onset in a series of 122 cases with FacioScapuloHumeral Muscular Dystrophy. Pastorello E; Cao M; Trevisan CP Clin Neurol Neurosurg; 2012 Apr; 114(3):230-4. PubMed ID: 22079131 [TBL] [Abstract][Full Text] [Related]
43. Natural History of Facioscapulohumeral Dystrophy in Children: A 2-Year Follow-up. Dijkstra JN; Goselink RJM; van Alfen N; de Groot IJM; Pelsma M; van der Stoep N; Theelen T; van Engelen BGM; Voermans NC; Erasmus CE Neurology; 2021 Nov; 97(21):e2103-e2113. PubMed ID: 34675094 [TBL] [Abstract][Full Text] [Related]
44. The Facioscapulohumeral Muscular Dystrophy-Health Index: Development and evaluation of a disease-specific outcome measure. Varma A; Weinstein J; Seabury J; Rosero S; Engebrecht C; Wagner E; Zizzi C; Luebbe EA; Dilek N; McDermott MP; Kissel J; Sansone V; Heatwole C Muscle Nerve; 2023 Oct; 68(4):422-431. PubMed ID: 37610084 [TBL] [Abstract][Full Text] [Related]
45. Convergence of patient- and physician-reported outcomes in the French National Registry of Facioscapulohumeral Dystrophy. Sanson B; Stalens C; Guien C; Villa L; Eng C; Rabarimeriarijaona S; Bernard R; Cintas P; Solé G; Tiffreau V; Echaniz-Laguna A; Magot A; Juntas Morales R; Boyer FC; Nadaj-Pakleza A; Jacquin-Piques A; Béroud C; Sacconi S; Orphanet J Rare Dis; 2022 Mar; 17(1):96. PubMed ID: 35236385 [TBL] [Abstract][Full Text] [Related]
46. Molecular diagnosis of facioscapulohumeral muscular dystrophy. Upadhyaya M; Cooper DN Expert Rev Mol Diagn; 2002 Mar; 2(2):160-71. PubMed ID: 11962336 [TBL] [Abstract][Full Text] [Related]
47. Fatigue in facioscapulohumeral muscular dystrophy: a qualitative study of people's experiences. Schipper K; Bakker M; Abma T Disabil Rehabil; 2017 Sep; 39(18):1840-1846. PubMed ID: 27762634 [TBL] [Abstract][Full Text] [Related]
48. Severe phenotype in infantile facioscapulohumeral muscular dystrophy. Klinge L; Eagle M; Haggerty ID; Roberts CE; Straub V; Bushby KM Neuromuscul Disord; 2006 Oct; 16(9-10):553-8. PubMed ID: 16934468 [TBL] [Abstract][Full Text] [Related]
49. Functional muscle impairment in facioscapulohumeral muscular dystrophy is correlated with oxidative stress and mitochondrial dysfunction. Turki A; Hayot M; Carnac G; Pillard F; Passerieux E; Bommart S; Raynaud de Mauverger E; Hugon G; Pincemail J; Pietri S; Lambert K; Belayew A; Vassetzky Y; Juntas Morales R; Mercier J; Laoudj-Chenivesse D Free Radic Biol Med; 2012 Sep; 53(5):1068-79. PubMed ID: 22796148 [TBL] [Abstract][Full Text] [Related]
51. Phenotypic Variability Among Patients With D4Z4 Reduced Allele Facioscapulohumeral Muscular Dystrophy. Ruggiero L; Mele F; Manganelli F; Bruzzese D; Ricci G; Vercelli L; Govi M; Vallarola A; Tripodi S; Villa L; Di Muzio A; Scarlato M; Bucci E; Antonini G; Maggi L; Rodolico C; Tomelleri G; Filosto M; Previtali S; Angelini C; Berardinelli A; Pegoraro E; Moggio M; Mongini T; Siciliano G; Santoro L; Tupler R JAMA Netw Open; 2020 May; 3(5):e204040. PubMed ID: 32356886 [TBL] [Abstract][Full Text] [Related]
52. Psychiatric disorders appear equally in patients with myotonic dystrophy, facioscapulohumeral dystrophy, and hereditary motor and sensory neuropathy type I. Kalkman JS; Schillings ML; Zwarts MJ; van Engelen BG; Bleijenberg G Acta Neurol Scand; 2007 Apr; 115(4):265-70. PubMed ID: 17376125 [TBL] [Abstract][Full Text] [Related]
53. An instrumented timed up and go in facioscapulohumeral muscular dystrophy. Huisinga J; Bruetsch A; Mccalley A; Currence M; Herbelin L; Jawdat O; Pasnoor M; Dimachkie M; Barohn R; Statland J Muscle Nerve; 2018 Mar; 57(3):503-506. PubMed ID: 28877559 [TBL] [Abstract][Full Text] [Related]
55. Updating the Clinical Picture of Facioscapulohumeral Muscular Dystrophy: Ramifications for Drug Development With Potential Solutions. Huml RA; Uspenskaya-Cadoz O; Dawson J; Slifer Z Ther Innov Regul Sci; 2020 Jan; 54(1):144-150. PubMed ID: 32008231 [TBL] [Abstract][Full Text] [Related]
56. Expression profile of FSHD supports a link between retinal vasculopathy and muscular dystrophy. Osborne RJ; Welle S; Venance SL; Thornton CA; Tawil R Neurology; 2007 Feb; 68(8):569-77. PubMed ID: 17151338 [TBL] [Abstract][Full Text] [Related]
57. Facioscapulohumeral muscular dystrophy: a radiologic and manometric study of the pharynx and esophagus. Stübgen JP Dysphagia; 2008 Dec; 23(4):341-7. PubMed ID: 18259705 [TBL] [Abstract][Full Text] [Related]
58. Facioscapulohumeral muscular dystrophy: epidemiological and molecular study in a north-east Italian population sample. Mostacciuolo ML; Pastorello E; Vazza G; Miorin M; Angelini C; Tomelleri G; Galluzzi G; Trevisan CP Clin Genet; 2009 Jun; 75(6):550-5. PubMed ID: 19320656 [TBL] [Abstract][Full Text] [Related]
59. Muscle MRI findings in facioscapulohumeral muscular dystrophy. Gerevini S; Scarlato M; Maggi L; Cava M; Caliendo G; Pasanisi B; Falini A; Previtali SC; Morandi L Eur Radiol; 2016 Mar; 26(3):693-705. PubMed ID: 26115655 [TBL] [Abstract][Full Text] [Related]
60. Quality of life and support needs in children, adolescents, and young adults with facioscapulohumeral dystrophy, a mixed-method study. Dijkstra JN; Rasing NB; Boon HTM; Altena-Rensen S; Cup EHC; Lanser A; Siemann IJ; van Engelen BG; Erasmus CE; Voermans NC Eur J Paediatr Neurol; 2024 May; 50():64-73. PubMed ID: 38692157 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]